Universitair Ziekenhuis (Uz) Leuven

Leuven 3000

1 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumors, Chronic Graft-versus-host-disease, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Gastrointestinal (GI) Malignancies, Idiopathic Pulmonary Fibrosis, Locally Advanced Solid Tumors, MPN (Myeloproliferative Neoplasms), Marginal Zone Lymphoma, Metastatic Solid Tumors, Non Hodgkin Lymphoma, Prurigo

Studies at this site

• A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease — Running, not enrolling
• A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) — Stopped early
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203) — Completed
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) — Completed
• Study of INCA 0186 in Subjects With Advanced Solid Tumors — Stopped early
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — Completed
• Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis — Completed